Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Cremaschi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomed Research International|August 15, 2015
An Association Rule Mining Approach to Discover lncRNAs Expression Patterns in Cancer DatasetsPaolo Cremaschi, Roberta Carriero, Stefania Astrologo, et al.
Plos One|July 10, 2015
γ-PGA Hydrolases of Phage Origin in Bacillus subtilis and Other Microbial GenomesStefania Mamberti, Paola Prati, Paolo Cremaschi, et al.
BMC Bioinformatics|February 26, 2014
CorrelaGenes: a new tool for the interpretation of the human transcriptomePaolo Cremaschi, Sergio Rovida, Lucia Sacchi, et al.
Plos One|July 8, 2015
Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective CellsPaolo Cremaschi, Matteo Oliverio, Valentina Leva, et al.
Cell Reports Methods|February 23, 2023
An interactive web application for processing, correcting, and visualizing genome-wide pooled CRISPR-Cas9 screensAlessandro Vinceti, Riccardo Roberto De Lucia, Paolo Cremaschi, et al.
Blood|August 19, 2024
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myelomaKatia Grillone, Serena Ascrizzi, Paolo Cremaschi, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate CancerNicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
European Urology Oncology|September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b TrialMaria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomed Research International|August 15, 2015
An Association Rule Mining Approach to Discover lncRNAs Expression Patterns in Cancer DatasetsPaolo Cremaschi, Roberta Carriero, Stefania Astrologo, et al.
Plos One|July 10, 2015
γ-PGA Hydrolases of Phage Origin in Bacillus subtilis and Other Microbial GenomesStefania Mamberti, Paola Prati, Paolo Cremaschi, et al.
BMC Bioinformatics|February 26, 2014
CorrelaGenes: a new tool for the interpretation of the human transcriptomePaolo Cremaschi, Sergio Rovida, Lucia Sacchi, et al.
Plos One|July 8, 2015
Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective CellsPaolo Cremaschi, Matteo Oliverio, Valentina Leva, et al.
Cell Reports Methods|February 23, 2023
An interactive web application for processing, correcting, and visualizing genome-wide pooled CRISPR-Cas9 screensAlessandro Vinceti, Riccardo Roberto De Lucia, Paolo Cremaschi, et al.
Blood|August 19, 2024
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myelomaKatia Grillone, Serena Ascrizzi, Paolo Cremaschi, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate CancerNicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
Nature Communications|August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clonesA M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
European Urology Oncology|September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b TrialMaria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
Pageof 2